Shared more. Cited more. Safe forever.
    • advanced search
    • submit works
    • about
    • help
    • contact us
    • login
    View Item 
    •   MOspace Home
    • University of Missouri-Columbia
    • College of Agriculture, Food and Natural Resources (MU)
    • Division of Applied Social Sciences (MU)
    • Department of Agricultural Economics (MU)
    • Economics and Management of Agrobiotechnology Center (MU)
    • AgBioForum (Journal)
    • AgBioForum, vol. 04, no. 1, (2001)
    • View Item
    •   MOspace Home
    • University of Missouri-Columbia
    • College of Agriculture, Food and Natural Resources (MU)
    • Division of Applied Social Sciences (MU)
    • Department of Agricultural Economics (MU)
    • Economics and Management of Agrobiotechnology Center (MU)
    • AgBioForum (Journal)
    • AgBioForum, vol. 04, no. 1, (2001)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    advanced searchsubmit worksabouthelpcontact us

    Browse

    All of MOspaceCommunities & CollectionsDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis SemesterThis CollectionDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis Semester

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular AuthorsStatistics by Referrer

    BASF : AgBio Fast Follower

    Wield, David
    View/Open
    [PDF] BASF.pdf (22.64Kb)
    Date
    2001
    Format
    Article
    Metadata
    [+] Show full item record
    Abstract
    BASF has been a latecomer to agrobiotechnology. Until mid-1998, BASF continued its longstanding focus on chemicals production with massive economies of scale, in particular, but also of scope. In 2000, it announced the acquisition of the Cyanamid (crop protection) part of American Home Products, roughly doubling its agrochemicals business to join the "big four" (with Syngenta, Aventis, and Monsanto). BASF moved into plant biotechnology in 1998, describing itself as a "fast follower," with a commitment to focus on second and third generation products. Investment in biotechnology research and development (R&D) has increased rapidly, now totaling around 20% of life sciences' R&D.
    URI
    http://hdl.handle.net/10355/351
    Citation
    AgBioForum, 4(1) 2001: 58-62.
    Rights
    OpenAccess.
    This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.
    Collections
    • AgBioForum, vol. 04, no. 1, (2001)

    Send Feedback
    hosted by University of Missouri Library Systems
     

     


    Send Feedback
    hosted by University of Missouri Library Systems